• Home
  • Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis.

Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis.

Author List
Tan IL, Perez AR, Lew RJ, Sun X, Baldwin A, Zhu YK, Shah MM, Berger MS, Doudna JA, Fellmann C
Publication
Cell reports
Publication ID (Profile URL)
https://researcherprofiles.org/profile/447961232
Publication Year
2023
PubMed ID
37917583
Publication Title
Tan IL, Perez AR, Lew RJ, Sun X, Baldwin A, Zhu YK, Shah MM, Berger MS, Doudna JA, Fellmann C. Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis. Cell Rep. 2023 11 28; 42(11):113339.